http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2011134033-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate | 2010-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2013-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2011134033-A |
| titleOfInvention | MEDICINAL FORM FOR TRANSMISSIONAL ORAL ADMINISTRATION OF ANALGETIC AND / OR ANTI-SPASMATIC MOLECULES |
| abstract | 1. Dosage form for transmucosal oral administration of at least one active substance intended for the treatment of a spastic attack, including: - at least one active substance present in the form of a base and / or in the form of a salt, selected from among antispasmodics peripheral action or nefopam, - an aqueous-alcoholic solution with a strength of at least 35 ° alcohol, and, if necessary, another active substance present in the form of a base and / or in the form of a salt, selected from as centrally acting analgesics, in which the active ingredient or active ingredients is present (dissolved) in a state of stable and complete dissolution in a hydroalcoholic rastvore.2. Dosage form according to claim 1, characterized in that the antispasmodic agents of peripheral action are selected from among thiemone or phloroglucin. Dosage form according to claim 1 or 2, characterized in that the central-acting analgesics are selected from paracetamol or nefopam. The dosage form according to claim 1 or 2, characterized in that the strength of the water-alcohol solution is from 35 to 70 ° alcohol. Dosage form according to claim 1 or 2, characterized in that the alcohol of the aqueous-alcoholic solution is ethanol. Dosage form according to claim 1 or 2, characterized in that it also includes a substance that corrects pH. The dosage form according to claim 6, characterized in that the pH-adjusting substance is selected from among sodium carbonates and bicarbonates, primary and secondary acid phosphates of sodium, triethanolamine, sodium hydroxide and potassium hydroxide and / or from acids: hydrochloric, sulfuric, yang |
| priorityDate | 2009-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 39.